# Clinical Evaluation of Shengdi Dahuang Decoction in the Treatment of Acute Hemorrhagic Stroke

Study · id `cardio:ct-nct04200781` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04200781](<https://clinicaltrials.gov/study/NCT04200781>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04200781

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 464 participants.

## Technical summary

Registry record NCT04200781. Randomized; double masking; primary purpose treatment. Start 2019-09-01 (actual); primary completion 2022-06-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 464 participants (planned count; ClinicalTrials.gov record NCT04200781, source copy `cardio:ctgov-nct04200781-2019-12-16`, retrieved 2026-10-26)
- Started: 2019-09-01 (actual) (ClinicalTrials.gov record NCT04200781, source copy `cardio:ctgov-nct04200781-2019-12-16`, retrieved 2026-10-26)
- Primary completion: 2022-06-30 (anticipated) (ClinicalTrials.gov record NCT04200781, source copy `cardio:ctgov-nct04200781-2019-12-16`, retrieved 2026-10-26)
- Completion: 2022-06-30 (anticipated) (ClinicalTrials.gov record NCT04200781, source copy `cardio:ctgov-nct04200781-2019-12-16`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04200781, source copy `cardio:ctgov-nct04200781-2019-12-16`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04200781-2019-12-16`, retrieved 2026-10-26)

## The registry's words

- Brief title: Clinical Evaluation of Shengdi Dahuang Decoction in the Treatment of Acute Hemorrhagic Stroke
- Condition: Hemorrhagic Stroke
- Intervention (Drug): Granules of Shengdi Dahuang Decoction
- Intervention (Drug): Placebo
- Lead sponsor: ShuGuang Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Treatment of acute intracerebral haemorrhage with a Chinese herbal formula (Shengdi Dahuang Decoction): a multicentre, double-blind, randomised, placebo-controlled trial (`cardio:pubmed-40752894`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 457b82583c61c5442b296fb43e384198f2633ced0d205c02ca99c3b54886c09f
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
